Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments.

Clinical research in cardiology : official journal of the German Cardiac Society·2019
Same author

Reversed root for entirely biological aortic valve and ascending aorta replacement in a patient with endocarditis and mediastinitis.

The Thoracic and cardiovascular surgeon·2011
Same author

Aortic valve reconstruction: why, when, and how?

The Thoracic and cardiovascular surgeon·2010
Same author

Comment on "Fracture of Colvin-Galloway future band in a patient with mitral valve annuloplasty" by Bauer et al., Thorac Cardiov Surg 2006; 54: 352 - 353.

The Thoracic and cardiovascular surgeon·2007
Same author

Late air embolism with interventional removal after isolated coronary artery bypass grafting.

The Journal of thoracic and cardiovascular surgery·2006
Same author

Opening and closure characteristics of different types of stented biological valves.

The Thoracic and cardiovascular surgeon·2006

Related Experiment Videos

[Bedside thrombelastography. Cost reduction in cardiac surgery].

G J Spalding1, M Hartrumpf, T Sierig

  • 1Herzchirurgie, Herzzentrum Brandenburg, Ladeburger Strasse 17, 16321 Bernau bei Berlin. g.spalding@immanuel.de

Der Anaesthesist
|May 23, 2007
PubMed
Summary

Implementing bedside rotational thromboelastometry (ROTEM) significantly reduced blood product costs in cardiac surgery. This cost-effective approach improved coagulation management and decreased overall expenditure.

Related Experiment Videos

Area of Science:

  • Cardiovascular Surgery
  • Anesthesiology
  • Transfusion Medicine

Background:

  • Increasing costs of blood and coagulation products in cardiac surgery due to demographic changes and antiplatelet medication.
  • Need for effective strategies to manage perioperative coagulation and control expenditure.

Purpose of the Study:

  • To evaluate the cost-effectiveness of bedside rotational thromboelastometry (ROTEM) in cardiac surgery.
  • To analyze the impact of ROTEM on the use of blood products and coagulation factors.
  • To develop a cost-effective treatment algorithm for perioperative coagulation disorders.

Main Methods:

  • Retrospective analysis of annual treatment costs for cardiosurgical patients before and after ROTEM implementation.
  • Assessment of cumulative numbers and costs of platelet concentrates (PltC), fresh frozen plasma (FFP), red blood cell units (RBC), and coagulation factors (PCC, rFVIIa, FXIII, fibrinogen).
  • Comparison of average monthly costs, rethoracotomies, and early mortality between the two periods.

Main Results:

  • ROTEM implementation led to a 25% decrease in RBC and 50% decrease in PltC expenditure.
  • Significant reductions in prothrombin complex concentrates (PCC) and factor XIII (FXIII) by 80%, with complete omission of rFVIIa.
  • Overall blood product costs decreased by 32% and coagulation factor costs by 50%, resulting in combined savings of 44%, outweighing ROTEM expenses.
  • Rethoracotomies decreased from 6.6% to 5.5%, while early mortality remained stable.

Conclusions:

  • Bedside ROTEM analysis enables selective substitution management, significantly reducing costs for perioperative coagulation disorders.
  • Cost savings from reduced blood and coagulation product use substantially exceed ROTEM implementation costs.
  • Differential coagulation management guided by ROTEM is a cost-effective strategy in cardiac surgery.